Drug Product Composition data of Mivacurium Chloride on PharmaCompass.com

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Canada

Canada

0

Australia

Australia

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

1 RELATED EXCIPIENT COMPANIES

1EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Mivacron, 106861-44-3, Mivacurium chloride (mixture of isomers), Bw-b 1090u, Mivacurium (dichloride), Bis[3-[(1r)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-ium-2-yl]propyl] (e)-oct-4-enedioate;dichloride
Molecular Formula
C58H80Cl2N2O14
Molecular Weight
1100.2  g/mol
InChI Key
WMSYWJSZGVOIJW-ONUALHDOSA-L

Mivacurium Chloride
An isoquinoline derivative that is used as a short-acting non-depolarizing agent.
1 2D Structure

Mivacurium Chloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
bis[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (E)-oct-4-enedioate;dichloride
2.1.2 InChI
InChI=1S/C58H80N2O14.2ClH/c1-59(25-21-41-35-47(63-3)49(65-5)37-43(41)45(59)29-39-31-51(67-7)57(71-11)52(32-39)68-8)23-17-27-73-55(61)19-15-13-14-16-20-56(62)74-28-18-24-60(2)26-22-42-36-48(64-4)50(66-6)38-44(42)46(60)30-40-33-53(69-9)58(72-12)54(34-40)70-10;;/h13-14,31-38,45-46H,15-30H2,1-12H3;2*1H/q+2;;/p-2/b14-13+;;/t45-,46-,59?,60?;;/m1../s1
2.1.3 InChI Key
WMSYWJSZGVOIJW-ONUALHDOSA-L
2.1.4 Canonical SMILES
C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)CCC=CCCC(=O)OCCC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C.[Cl-].[Cl-]
2.1.5 Isomeric SMILES
C[N+]1(CCC2=CC(=C(C=C2[C@H]1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+]4(CCC5=CC(=C(C=C5[C@H]4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C.[Cl-].[Cl-]
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Bw B 1090u

2. Bw B1090u

3. Bw-b 1090u

4. Bw-b-1090u

5. Bw-b1090u

6. Bwb 1090u

7. Bwb1090u

8. Mivacron

9. Mivacurium

2.2.2 Depositor-Supplied Synonyms

1. Mivacron

2. 106861-44-3

3. Mivacurium Chloride (mixture Of Isomers)

4. Bw-b 1090u

5. Mivacurium (dichloride)

6. Bis[3-[(1r)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1h-isoquinolin-2-ium-2-yl]propyl] (e)-oct-4-enedioate;dichloride

7. Bwb109ou

8. Bw B109ou Dichloride

9. Mivacurii Chloridum

10. Mivacurii Chloridum [latin]

11. Cloruro De Mivacurio

12. Cloruro De Mivacurio [spanish]

13. Chlorure De Mivacurium

14. Chlorure De Mivacurium [french]

15. Ncgc00167469-01

16. Mivacurium Chloride [usan:inn:ban]

17. Unii-600zg213c3

18. Bw-b1090u

19. Mivacron (tn)

20. Mivacron In Dextrose 5% In Plastic Container

21. Bw B1090u Dichloride

22. Chembl984

23. Dsstox_cid_26649

24. Dsstox_rid_81794

25. Dsstox_gsid_46649

26. Schembl41232

27. (r)-1,2,3,4-tetrahydro-2-(3-hydroxypropyl)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)isoquinolinium Chloride, (e)-4-octenedioate (2:1)

28. Bw-b109ou Dichloride

29. Bw-1090u Dichloride

30. Chebi:6959

31. Dtxsid5046649

32. Schembl10666657

33. Hy-b1700a

34. Mivacurium Chloride (usan/inn)

35. Hms3886m16

36. Tox21_112473

37. Akos025311198

38. 600zg213c3

39. Isoquinolinium, 2,2'-((1,8-dioxo-4-octene-1,8-diyl)bis(oxy-3,1-propanediyl))bis(1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-((3,4,5-trimethoxyphenyl)methyl)-, Dichloride, (r-(r*,r*-(e)))-

40. Cas-106861-44-3

41. Cs-0013697

42. D00763

43. Q27263131

2.3 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 1100.2 g/mol
Molecular Formula C58H80Cl2N2O14
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count16
Rotatable Bond Count30
Exact Mass1098.4986606 g/mol
Monoisotopic Mass1098.4986606 g/mol
Topological Polar Surface Area145 Ų
Heavy Atom Count76
Formal Charge0
Complexity1550
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count2
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Neuromuscular Nondepolarizing Agents

Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. (See all compounds classified as Neuromuscular Nondepolarizing Agents.)


4.2 ATC Code

M - Musculo-skeletal system

M03 - Muscle relaxants

M03A - Muscle relaxants, peripherally acting agents

M03AC - Other quaternary ammonium compounds

M03AC10 - Mivacurium chloride


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Import","activeIngredients":"MIVACURIUM CHLORIDE","year":"2021","qtr":"Q1","strtotime":1609785000,"product":"MIVACURIUM CHLORIDE , 81 GRAMS ( NOT FOR SALE , LAB TESTING SAMPLE )","address":"A-8, II FLOOR AISHYWARYA COMPLEXRUKMINIPURI COLONY DR.A S RAO NAGAR","city":"HYDERABAD.AP","supplier":"ASPEN API","supplierCountry":"SOUTH AFRICA","foreign_port":"JOHANNESBURG - JOHAN","customer":"ALPHAMED FORMULATIONS PRIVATE ","customerCountry":"INDIA","quantity":"0.81","actualQuantity":"0.81","unit":"KGS","unitRateFc":"100","totalValueFC":"82.5","currency":"USD","unitRateINR":"7445","date":"05-Jan-2021","totalValueINR":"6030.45","totalValueInUsd":"82.5","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"2237346","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SOUTH AFRICA","selfForZScoreResived":"Pharma Grade","supplierPort":"JOHANNESBURG - JOHAN","supplierAddress":"","customerAddress":"A-8, II FLOOR AISHYWARYA COMPLEXRUKMINIPURI COLONY DR.A S RAO NAGAR"}]
05-Jan-2021
05-Jan-2021
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - SOLUTION;INTRAVENOUS - EQ 10MG BASE/...DOSAGE - SOLUTION;INTRAVENOUS - EQ 10MG BASE/5ML (EQ 2MG BASE/ML)

USFDA APPLICATION NUMBER - 20098

read-more

DOSAGE - SOLUTION;INTRAVENOUS - EQ 20MG BASE/...DOSAGE - SOLUTION;INTRAVENOUS - EQ 20MG BASE/10ML (EQ 2MG BASE/ML)

USFDA APPLICATION NUMBER - 20098

read-more

DOSAGE - SOLUTION;INTRAVENOUS - EQ 2MG BASE/M...DOSAGE - SOLUTION;INTRAVENOUS - EQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 20098

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty